Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Why Do Companies Outsource Offshore; Case Study

Tags

  • devices
  • which
  • product
  • combination products
  • companies involved

  • Links

  • Poker Rakeback - An Easy Way To Be Rich
  • Paradors of Spain
  • 29 Critical Questions to Ask a Realtor Before You List
  • Digg It - Why Do Companies Outsource Offshore; Case Study

    So why do so many American Companies offshore overseas? You know the real p
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    roblem is the over regulation and the over lawyering in the United States.
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    t gets to the point with all the rules and regulations and government agenc
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    es screwing with you and people like Elliot Spitzer threatening to do a PR
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rive bye shooting on your company, stock valuations and such, that it is no
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    really worth dealing with.

    It is not only about cheap labor, although sha
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    eholders equity and quarterly profits are king indeed. You see this is the
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    yn Rand affect as much as anything else. It is also an issue of money flows
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    and cycles, these issues have plagued civilization for thousands of years a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    d cheap imported linen from Asia and Far Middle East nearly took down the U
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    . In the Deming years we got cocky too, over unioned and regulated our Auto
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    Makers then too.

    We need to pay attention to money flows all the way aroun
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    , Mexico, Canada, Malaysia, China, India, Singapore, Japan, South Korea, Br
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    zil, Argentina, Columbia and this oil issue in the Middle East we send way
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    oo much money away and it is not re-circulating because we do not make anyt
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ing in America anymore except maybe hamburgers [okay bad joke].

    If we woul
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    treat our companies here with respect and not over regulate them, over law
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    er them and call them evil for merely participating in capitalism and free
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    arkets we could do a lot better off in America and we would then see an imm
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    diate reduction in offshoring and overseas job loses. Think on this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/3677/diggit-Why-Do-Companies-Outsource-Offshore-Case-Study.html">Why Do Companies Outsource Offshore; Case Study</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/3677/diggit-Why-Do-Companies-Outsource-Offshore-Case-Study.html]Why Do Companies Outsource Offshore; Case Study[/url]

    Related Articles:

    Money Clips: The Perfect Executive Gifts for the Savvy Giver

    Buying a Business in Australia - Market has Hot and Cold Spots

    Business Incorporation Explained

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com